The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relationship of loss of miRNA-296 in the circulation and clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer.
Sameh Mikhail
No relevant relationships to disclose
Narayan Shivapurkar
No relevant relationships to disclose
Wei Bai
No relevant relationships to disclose
John Marshall
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Jimmy J. Hwang
No relevant relationships to disclose
Michael J. Pishvaian
No relevant relationships to disclose
Anton Wellstein
No relevant relationships to disclose
Aiwu Ruth He
No relevant relationships to disclose